Digest Network Come funziona
Network
/
Società
Se
Non verificato

SetPoint Medical

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaEventiIndustriaSalute

11 comunicati stampa

Guarda tutti i comunicati
25/11/2025
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Biotecnologia
Eventi
Fiere
SetPoint Medical to Present at Piper Sandler 37th Annual Healthcare Conference
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
24/11/2025
Industria
Biotecnologia
Salute
Medicina - Varie
Attrezzature medico-sanitarie
SetPoint Medical Announces CMS Transitional Pass-Through Payment Approval for the SetPoint System, the Breakthrough Neuroimmune Modulation Platform
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
25/10/2025
Eventi
Industria
Scienza
Medicina nucleare
Biotecnologia
Sanità
Salute
Attrezzature medico-sanitarie
SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
11/08/2025
Biotecnologia
Salute
Attrezzature medico-sanitarie
SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
31/07/2025
SetPoint Medical Receives FDA Approval for Novel Neuroimmune Modulation Therapy for Rheumatoid Arthritis
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
11/06/2025
Sanità
Salute
Scienza
Medicina - Varie
Eventi
Industria
SetPoint Medical Receives Clinical Research Award at EULAR 2025 Congress
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
04/06/2025
Mercato del lavoro
Attrezzature medico-sanitarie
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
SetPoint Medical Appoints Tyler Binney to Its Board of Directors
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
09/12/2024
Industria
Biotecnologia
Igiene alimentare
Salute
Attrezzature medico-sanitarie
SetPoint Medical Announces Filing of Premarket Approval (PMA) Application to the U.S. Food and Drug Administration (FDA) for Novel Neuroimmune Modulation Device for the Treatment of Rheumatoid Arthritis
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
18/11/2024
SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0
02/10/2024
Industria
Scienza
Attrezzature medico-sanitarie
Igiene alimentare
Medicina - Varie
Salute
Vetrine/Shopping
SetPoint Medical Receives FDA’s IDE Approval for U.S. Pilot Study of Neuroimmune Modulation Platform in Adults with Relapsing-Remitting Multiple Sclerosis
Fonte
SetPoint Medical
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0